CN Patent
CN101410097A — 软明胶胶囊制剂
Assigned to Sucampo GmbH · Expires 2009-04-15 · 17y expired
What this patent protects
本发明公开了一种15-酮-前列腺素化合物的软明胶胶囊制剂,所述制剂包含:明胶和作为增塑剂的糖醇的软明胶胶囊壳,和填充于所述胶囊壳中的包含15-酮-前列腺素化合物和可药用载体的混合物。通过将15-酮-前列腺素化合物加入所述软明胶胶囊壳,所述化合物的稳定性得到明显提高。
USPTO Abstract
本发明公开了一种15-酮-前列腺素化合物的软明胶胶囊制剂,所述制剂包含:明胶和作为增塑剂的糖醇的软明胶胶囊壳,和填充于所述胶囊壳中的包含15-酮-前列腺素化合物和可药用载体的混合物。通过将15-酮-前列腺素化合物加入所述软明胶胶囊壳,所述化合物的稳定性得到明显提高。
Drugs covered by this patent
- Amitiza (LUBIPROSTONE) · Sucampo Pharma Llc
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.